Applicants should have a PhD in bioinformatics, biostatistics, statistics, computer science, systems biology, or a related discipline.... $37,000 - $45,000 a year
From Research Foundation of The City University of New York - Wed, 08 Mar 2017 20:47:10 GMT - View all New York jobs

Funding Opportunity RFA-DA-18-003 from the NIH Guide for Grants and Contracts. The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use. Eligible applicants must demonstrate the ability to develop molecules with the potential to treat SUDs and advance them in the drug development continuum. The ultimate goal of this FOA is to bring molecules closer to FDA approval. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. The UG3 will support a project with specific milestones to be accomplished at the end of the 2-year period. The UH3 will provide funding for 3 years to a project that successfully completed the milestones set in the UG3. UG3 projects that have met their milestones will be administratively considered by NIDA and prioritized for transition to the UH3 phase. Investigators responding to this FOA must address both UG3 and UH3 phases. Through this FOA, NIDA seeks to attract exceptionally talented investigators to the mission of expanding the number and breadth of lead molecules in the pipeline for drug addiction treatment, optimizing these leads, and/or advancing them to clinical testing.

Background in healthcare, bioinformatics, genetics, genomics, molecular biology. Highly productive and can get first pass implementations of even complicated...
From GNS Healthcare - Wed, 08 Mar 2017 16:53:48 GMT - View all Cambridge jobs

The goal of this exciting initiative is to leverage existing strengths in the integration and analysis of pathogen genomics and functional data to incorporate...
From Indeed - Wed, 08 Mar 2017 16:20:05 GMT - View all Athens, GA jobs

Experience with Statistical Analysis. Requires a bachelor's degree in Computer Science or related fields or equivalent in education and experience, plus two...
From Columbia University - Wed, 08 Mar 2017 15:13:44 GMT - View all New York jobs

Funding Opportunity PAR-17-206 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue support for the program referred to as the Alliance of Glycobiologists for Cancer Research (http://glycomics.cancer.gov). Through this FOA, the NCI encourages research projects to elucidate how changes in cellular carbohydrates may promote cancer initiation and progression and use this information to identify glycan-based abnormalities to serve as biomarkers for early cancer detection or risk assessment. These changes may be studied at the level of glycoproteins, glycolipids, glycosaminoglycans, and/or their binding proteins. In their applications, applicants are encouraged to address the ability of these biomarker candidates to accurately distinguish individuals with cancer from those without. It is expected that the most promising biomarker candidates will ultimately be tested in clinical validation studies, although such validation studies are not required for the proposed projects. All investigators with appropriate expertise and capabilities, irrespective of any prior association with this Alliance, are encouraged to consider applying to this FOA.

Funding Opportunity PAR-17-207 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is intended to support research applications that are focused on mechanisms that mediate alterations in glycosylation during oncogenesis. The goal of this FOA is to advance our knowledge of altered glycosylation or other modifications in carbohydrate structure in cancer to determine whether it is the cause or the result of neoplastic transformation. Because the research is intended to examine the biology of how modifications in carbohydrate structure influence malignancy during different stages of the disease, this FOA will support research teams that have complementary expertise in glycobiology and cancer biology to focus on mechanisms that mediate alterations in glycosylation during oncogenesis.

GBP31498 - GBP39729 per annum + excellent benefits: Wellcome Trust Sanger Institute: The group, led by Phil Jones, studies pre-cancer, how mutant cells evolve into cancers in humans and model systems (http://www.sanger.ac.uk/science... Cambridgeshire, England

Please also send CV, a brief research statement, and contact information of three references to changk@cshl.edu....
From Cold Spring Harbor Laboratory - Wed, 08 Mar 2017 11:40:01 GMT - View all Cold Spring Harbor jobs

In a relevant field, such as Applied Math, Statistics, Computer Science, Physics, Economics, Electrical Engineering, or Bioinformatics....
From TIAA - Wed, 08 Mar 2017 11:05:55 GMT - View all New York jobs

Negotiable: Wellcome Trust Sanger Institute: We are looking for a senior C software developer to work on samtools, one of the world's most popular bioinformatics software packages. Hinxton, England

Funding Opportunity PAR-17-209 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of General Medical Sciences (NIGMS) R25 program is to support educational activities that enhance the diversity of the biomedical research workforce. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development and Research Experiences.

Funding Opportunity PAR-17-210 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of General Medical Sciences (NIGMS) R25 program is to support educational activities that enhance the diversity of the biomedical research workforce. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development, Research Experiences, and Curriculum or Methods Development. A program application must include each activity, and describe how they will be synergized to make a comprehensive program.

Funding Opportunity PAR-17-208 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.

Duties include GWAS and NGS data analysis, PLINK and R statistical analysis, exome and RNA sequencing, and utilize tools for genome and transcriptome...
From Columbia University - Wed, 08 Mar 2017 07:14:57 GMT - View all New York jobs

Notice NOT-NS-17-018 from the NIH Guide for Grants and Contracts

Amazon EMR securely and reliably handles your big data use cases, including log analysis, web indexing, data warehousing, machine learning, financial analysis,...
From Amazon.com - Wed, 08 Mar 2017 06:49:39 GMT - View all New York jobs

Please do not submit resumes unless authorized to do so. The digital genomics system consists a fully integrated sequencing platform, consumables and...
From Bio-Rad Inc. - Wed, 08 Mar 2017 06:44:50 GMT - View all Cambridge jobs

Computational Biology and Bioinformatics including quality assessment, analysis, interpretation and visualization of high-throughput sequencing data....
From DuPont - Tue, 07 Mar 2017 22:14:40 GMT - View all Johnston jobs

Experimental design, mixed models, Bayesian methods, linear and nonlinear regression, repeated measures, machine learning algorithms, analysis of high...
From GlaxoSmithKline - Tue, 07 Mar 2017 19:54:57 GMT - View all jobs